Preclinical proof of principle for orally delivered Th17 antagonist miniproteinsCellJune 26, 202410.1016/j.cell.2024.05.052Cited by 78SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis